PBMC from patients with CL and ML produce more IL-17 than do cells from uninfected individuals, and this cytokine is also present in the lesions of these leishmaniasis patients [6,8], indicating that it may participate in the tissue destruction observed in this disease. This evidence concerns the gene IL17A and leishmaniasis.